SCHEMBL387422

SCHEMBL387422

CCC/[C]=C/CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL387421 1.00
SCHEMBL6234338 0.92 TSHR (0.40)
SCHEMBL7176245 0.92 TSHR (0.40)
SCHEMBL6234335 0.92 TSHR (0.40)
SCHEMBL7181851 0.90 TSHR (0.44)
SCHEMBL7183482 0.90 TSHR (0.44)
SCHEMBL7190443 0.90 TSHR (0.44)
SCHEMBL5736278 0.90 TSHR (0.44)
SCHEMBL7183636 0.90 TSHR (0.44)
SCHEMBL7181754 0.90 TSHR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139926-A Resin composition 株式会社可乐丽 2024-06-04 CN disclosed
CN-118139909-A Beta-methyl-delta-valerolactone based polymer 株式会社可乐丽 2024-06-04 CN disclosed
WO-2023068345-A1 Β-METHYL-δ-VALEROLACTONE POLYMER 株式会社クラレ 2023-04-27 WO disclosed
WO-2023068348-A1 RESIN COMPOSITION 株式会社クラレ 2023-04-27 WO disclosed
WO-2023068346-A1 Β-METHYL-δ-VALEROLACTONE POLYMER 株式会社クラレ 2023-04-27 WO disclosed
US-8101650-B2 Method for treating a immunology-related disease DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-24 US disclosed
US-8067396-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2011-11-29 US disclosed
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2010-02-11 US disclosed
US-20090326038-A1 Method for treating a immunology-related disease SANKYO COMPANY, LIMITED (JP) 2009-12-31 US disclosed
US-7638551-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2009-12-29 US disclosed
US-6762168-B2 ANTIBACTERIAL COMPOUNDS. THE INVENTION CONCERNS MACROLIDE ANTIBIOTICS USEFUL AS ANTIINFECTIVE AGENTS. KOSAN BIOSCIENCES, INC. 2004-07-13 US disclosed
US-20040132784-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-08 US disclosed
US-6723745-B2 PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL SANKYO COMPANY, LIMITED (JP) 2004-04-20 US disclosed
US-20030236297-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2003-12-25 US disclosed
EP-0938842-B1 Sustained release pheromone dispenser SHINETSU CHEMICAL CO (JP) 2003-10-15 EP disclosed
EP-1300405-A1 AMINO ALCOHOL DERIVATIVES Sankyo Company, Limited (JP) 2003-04-09 EP disclosed
US-6355236-B2 Sustained release pheromone formation SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-03-12 US disclosed
US-20010053372-A1 SUSTAINED RELEASE PHEROMONE FORMATION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2001-12-20 US disclosed
EP-0938842-A1 Sustained release pheromone dispenser SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-09-01 EP disclosed
EP-0206621-A1 Process for disproportionating silanes MITSUI TOATSU CHEMICALS, Inc. (JP) 1986-12-30 EP disclosed